Exploring patients' expectations and preferences of glaucoma surgery outcomes to facilitate healthcare delivery and inform future glaucoma research.
Aged
Aged, 80 and over
Biomedical Research
Delivery of Health Care
Female
Focus Groups
Glaucoma
/ drug therapy
Humans
Intraocular Pressure
/ physiology
Male
Middle Aged
Patient Preference
/ psychology
Patient Reported Outcome Measures
Patient Satisfaction
Tonometry, Ocular
Trabeculectomy
Visual Acuity
/ physiology
Visual Fields
/ physiology
field of vision
glaucoma
intraocular pressure
treatment surgery
vision
Journal
The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
16
10
2018
revised:
13
02
2019
accepted:
22
02
2019
pubmed:
5
4
2019
medline:
30
5
2020
entrez:
5
4
2019
Statut:
ppublish
Résumé
Glaucoma is a lifelong condition often requiring surgical intervention. To allow us to inform patients' expectations of surgery effectively, it is important to understand patients' preferences and concerns regarding outcomes from glaucoma treatments including surgery. To explore what clinical and social outcomes of glaucoma surgery are important to patients. Forty-five glaucoma patients undergoing medical glaucoma treatments or surgery were recruited for focus group interviews to determine their opinions regarding the outcomes of glaucoma treatments. Thematic analysis was performed with NVivo software. Themes identified were understanding glaucoma, understanding surgery treatments and understanding treatment outcomes. The most important outcomes of the glaucoma surgery reported by the patients were social factors. Patients felt that being able to maintain their driving licence is a strong indicator of successful glaucoma treatment/surgery. Other important outcomes were independent living, ability to care for their family and having a good-quality social life. When considering novel surgical treatments, most patients felt that certainty of successful outcome and proven longevity of the effect are the primary motivators for choosing these treatments. Patients understood that clinical measures were surrogates for maintaining visual function, but ability to maintain independent living was the most important outcome from their treatment. For newer treatments patients wished to know more about long-term outcomes when considering this option.
Identifiants
pubmed: 30944102
pii: bjophthalmol-2018-313401
doi: 10.1136/bjophthalmol-2018-313401
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1850-1855Informations de copyright
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.